Alpha-Stim
Showing 51 - 75 of 2,723
Vestibular Function Disorder Trial in San Antonio (Alpha Lipoic Acid 300mg, Coenzyme Q10 200mg)
Not yet recruiting
- Vestibular Function Disorder
- Alpha Lipoic Acid 300mg
- Coenzyme Q10 200mg
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio
Jul 5, 2023
Ischemic Cardiomyopathy, Diabetes Trial in Damanhur (Alpha Lipoic Acid 600 MG Oral Tablet, Placebo Tablet)
Recruiting
- Ischemic Cardiomyopathy
- Diabetes Mellitus
- Alpha Lipoic Acid 600 MG Oral Tablet
- Placebo Tablet
-
Damanhūr, Elbehairah, EgyptDamanhour Teaching Hospital, General Organization for Teaching H
Sep 26, 2023
Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and
Recruiting
- Lymphomatoid Granulomatosis
- +3 more
- Interferon
- Rituxan and EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Dexmedetomidine, Propofol, Mechanical Ventilation Trial in Tanta (Dexmedetomidine, Propofol)
Recruiting
- Dexmedetomidine
- +4 more
-
Tanta, El-Gharbia, EgyptTanta University
Oct 24, 2023
European Alpha-Mannosidosis Participant
Terminated
- Immunodeficiency
- +5 more
-
Aachen, Germany
- +18 more
Jun 10, 2022
Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)
Recruiting
- Metabolic Associated Fatty Liver Disease
- LUDLEV®300 mg/46.2 mg
- Placebo
-
Mexico, Veracruz, MexicoAna Delfina Cano Contreras
Jun 12, 2023
The Longitudinal Study of Stimulant Use Disorder
Not yet recruiting
- Stimulant Use
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Oct 3, 2023
Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Radiation: Diffusing Alpha Radiation
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
- (no location specified)
Dec 11, 2022
Alpha-lactalbumin, Microbiota, Dysbiosis Trial in Viterbo (Alpha-lactalbumin)
Recruiting
- Alpha-lactalbumin
- +2 more
- Alpha-lactalbumin
-
Viterbo, Rome, ItalyCentro Polispecialistico Giovanni Paolo I°
Jan 31, 2023
Experimental Pain in Healthy Human Subjects Trial in Munich (attention right training, ARTNF, attention left training, ALTNF,
Recruiting
- Experimental Pain in Healthy Human Subjects
- attention right training, ARTNF
- +3 more
-
Munich, Bavaria, GermanyDepartment of Neurology, Klinikum rechts der Isar, Technical Uni
Oct 5, 2022
COVID-19 Trial in Kunming (RQ3013, RQ3025, RQ3027)
Recruiting
- COVID-19
- RQ3013
- +2 more
-
Kunming, Yunnan, ChinaThe Affiliated Hospital of Yunnan University
Jun 22, 2023
Sleep, Sleep Disturbance Trial in Cambridge (Elemind Neuromodulation (ENMod))
Recruiting
- Sleep
- Sleep Disturbance
- Elemind Neuromodulation (ENMod)
-
Cambridge, MassachusettsElemind Technologies, Inc
Feb 14, 2023
Alpha-1 Antitrypsin Deficiency Trial in San Diego, Boston, Saint Louis (Liver Biopsy (Biopsy Group Only))
Recruiting
- Alpha-1 Antitrypsin Deficiency
- Liver Biopsy (Biopsy Group Only)
-
San Diego, California
- +2 more
Dec 13, 2022
Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,
Recruiting
- Glaucoma, Suspect
- Aberration, Corneal Wavefront
- Low dosage selective alpha-2 receptor agonists topical eyedrop
- High dosage selective alpha-2 receptor agonists topical eyedrop
-
Banhā, QA, EgyptAhmed Abdelshafy
Jan 2, 2023
Adult Gliomas, Mixed Trial in San Francisco (Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG), Magnetic Resonance Image
Recruiting
- Adult Gliomas, Mixed
- Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)
- Magnetic Resonance Image (MRI)
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 9, 2023
NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)
Recruiting
- Non-small Cell Lung Cancer
- Hypofractionated radiotherapy
- +4 more
-
Guangzhou, Guangdong, ChinaSun yat-sen university cancer center
Nov 14, 2023
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Recurrent Lung Cancer, Lung Cancer Trial (Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT))
Not yet recruiting
- Recurrent Lung Cancer
- Lung Cancer
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
- (no location specified)
Nov 21, 2022
DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)
Not yet recruiting
- Diabetes MellitusType 1
- Placebo
- Alpha Lipoic Acid 600 MG Oral Capsule
- (no location specified)
Jan 8, 2023
Ischemic Stroke Trial (TS23)
Not yet recruiting
- Ischemic Stroke
- TS23
- (no location specified)
Jul 14, 2023
Ulcerative Colitis Trial ("Mesalamine" and "alpha-lipoic acid", "Mesalamine" and "Placebo")
Not yet recruiting
- Ulcerative Colitis
- "Mesalamine" and "alpha-lipoic acid"
- "Mesalamine" and "Placebo"
- (no location specified)
Oct 5, 2023
Cardiovascular Biomarkers in Peripheral Artery Disease.
Active, not recruiting
- Peripheral Artery Disease
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Feb 24, 2023
Pheochromocytoma, Paraganglioma, Adrenalectomy; Status Trial in Seoul (Phenoxybenzamine)
Recruiting
- Pheochromocytoma
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 18, 2023
Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))
Not yet recruiting
- Pompe Disease
- +7 more
- Multi-ingredient supplement (PDT-MIS)
- Placebo (PLA)
- (no location specified)
Nov 8, 2023
Healthy Trial (NeuroConn Plus Stimulator tACS, NeuroConn Plus Stimulator Sham)
Completed
- Healthy
- NeuroConn Plus Stimulator tACS
- NeuroConn Plus Stimulator Sham
- (no location specified)
Aug 14, 2019